{
    "Trade/Device Name(s)": [
        "AtheNA Multi-Lyte Borrelia VlsE-1/pepC10 Plus Test System"
    ],
    "Submitter Information": "Zeus Scientific, Inc.",
    "510(k) Number": "K100728",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSR"
    ],
    "Summary Letter Date": "March 10, 2010",
    "Summary Letter Received Date": "April 9, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "VlsE-1 IgG antibody",
        "pepC10 IgM antibody"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Luminex 200 IS",
        "AtheNA Multi-Lyte Data Analysis Package Version 3.0"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplexed sandwich immunoassay",
        "Micro particle immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Immunoassay",
        "Multiplex bead-based immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Software",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for AtheNA Multi-Lyte Borrelia VlsE-1/pepC10 Plus Test System detecting antibodies to Borrelia in human serum using a multiplexed bead-based immunoassay platform.",
    "Indications for Use Summary": "Qualitative detection of IgG antibody to recombinant VlsE-1 and IgM antibody to synthetic pepC10 in human serum for patients with symptoms or history of Lyme Borreliosis; all positives require confirmation with second-tier test such as Western Blot.",
    "fda_folder": "Microbiology"
}